Corin overexpression improves cardiac function, heart failure, and survival in mice with dilated cardiomyopathy

Inna Gladysheva, Dong Wang, Rachel A. McNamee, Aiilyan K. Houng, Almois A. Mohamad, Tai-Hwang Fan, Guy Reed

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Heart failure, caused by dilated cardiomyopathy and other cardiac disorders such as hypertension, is a major public health problem with high morbidity and mortality. Corin, a cardiac enzyme that cleaves natriuretic peptides, is a promising biomarker of cardiomyopathy and heart failure, but its functional role in these processes is not understood. We evaluated the potential effects of corin in mice with a well-characterized model of dilated cardiomyopathy. Mice with dilated cardiomyopathy developed heart failure, reduced contractile function, cardiac fibrosis, and accelerated mortality in the setting of low corin expression. In wild-type mice, transgenic, cardiac-targeted, overexpression of corin enhanced cyclic guanosine monophosphate and blood pressure responses to pro-atrial natriuretic peptide, but did not affect heart size, contractility, body weights, survival, and blood pressure. In mice with dilated cardiomyopathy, corin overexpression significantly reduced the development of myocardial fibrosis (P<0.05). Corin overexpression also enhanced heart contractile function (fractional shortening and ejection fraction; P<0.01) and it significantly reduced heart failure as assessed by lung water (P<0.05) and alveolar congestion (P<0.001). Consistent with these observations, corin overexpression significantly prolonged life in mice with dilated cardiomyopathy (P<0.0001). These results provide the first experimental evidence that corin expression plays a role in cardiomyopathy by modulating myocardial fibrosis, cardiac function, heart failure, and survival.

Original languageEnglish (US)
Pages (from-to)327-332
Number of pages6
JournalHypertension
Volume61
Issue number2
DOIs
StatePublished - Feb 1 2013

Fingerprint

Dilated Cardiomyopathy
Heart Failure
Fibrosis
Cardiomyopathies
Blood Pressure
Myocardial Contraction
Natriuretic Peptides
Mortality
Cyclic GMP
Atrial Natriuretic Factor
Transgenic Mice
Public Health
Biomarkers
Body Weight
Hypertension
Morbidity
Lung
Water
Enzymes

All Science Journal Classification (ASJC) codes

  • Internal Medicine

Cite this

Corin overexpression improves cardiac function, heart failure, and survival in mice with dilated cardiomyopathy. / Gladysheva, Inna; Wang, Dong; McNamee, Rachel A.; Houng, Aiilyan K.; Mohamad, Almois A.; Fan, Tai-Hwang; Reed, Guy.

In: Hypertension, Vol. 61, No. 2, 01.02.2013, p. 327-332.

Research output: Contribution to journalArticle

Gladysheva, Inna ; Wang, Dong ; McNamee, Rachel A. ; Houng, Aiilyan K. ; Mohamad, Almois A. ; Fan, Tai-Hwang ; Reed, Guy. / Corin overexpression improves cardiac function, heart failure, and survival in mice with dilated cardiomyopathy. In: Hypertension. 2013 ; Vol. 61, No. 2. pp. 327-332.
@article{d7212f55c5b14c08805e888d311a649a,
title = "Corin overexpression improves cardiac function, heart failure, and survival in mice with dilated cardiomyopathy",
abstract = "Heart failure, caused by dilated cardiomyopathy and other cardiac disorders such as hypertension, is a major public health problem with high morbidity and mortality. Corin, a cardiac enzyme that cleaves natriuretic peptides, is a promising biomarker of cardiomyopathy and heart failure, but its functional role in these processes is not understood. We evaluated the potential effects of corin in mice with a well-characterized model of dilated cardiomyopathy. Mice with dilated cardiomyopathy developed heart failure, reduced contractile function, cardiac fibrosis, and accelerated mortality in the setting of low corin expression. In wild-type mice, transgenic, cardiac-targeted, overexpression of corin enhanced cyclic guanosine monophosphate and blood pressure responses to pro-atrial natriuretic peptide, but did not affect heart size, contractility, body weights, survival, and blood pressure. In mice with dilated cardiomyopathy, corin overexpression significantly reduced the development of myocardial fibrosis (P<0.05). Corin overexpression also enhanced heart contractile function (fractional shortening and ejection fraction; P<0.01) and it significantly reduced heart failure as assessed by lung water (P<0.05) and alveolar congestion (P<0.001). Consistent with these observations, corin overexpression significantly prolonged life in mice with dilated cardiomyopathy (P<0.0001). These results provide the first experimental evidence that corin expression plays a role in cardiomyopathy by modulating myocardial fibrosis, cardiac function, heart failure, and survival.",
author = "Inna Gladysheva and Dong Wang and McNamee, {Rachel A.} and Houng, {Aiilyan K.} and Mohamad, {Almois A.} and Tai-Hwang Fan and Guy Reed",
year = "2013",
month = "2",
day = "1",
doi = "10.1161/HYPERTENSIONAHA.112.193631",
language = "English (US)",
volume = "61",
pages = "327--332",
journal = "Hypertension",
issn = "0194-911X",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Corin overexpression improves cardiac function, heart failure, and survival in mice with dilated cardiomyopathy

AU - Gladysheva, Inna

AU - Wang, Dong

AU - McNamee, Rachel A.

AU - Houng, Aiilyan K.

AU - Mohamad, Almois A.

AU - Fan, Tai-Hwang

AU - Reed, Guy

PY - 2013/2/1

Y1 - 2013/2/1

N2 - Heart failure, caused by dilated cardiomyopathy and other cardiac disorders such as hypertension, is a major public health problem with high morbidity and mortality. Corin, a cardiac enzyme that cleaves natriuretic peptides, is a promising biomarker of cardiomyopathy and heart failure, but its functional role in these processes is not understood. We evaluated the potential effects of corin in mice with a well-characterized model of dilated cardiomyopathy. Mice with dilated cardiomyopathy developed heart failure, reduced contractile function, cardiac fibrosis, and accelerated mortality in the setting of low corin expression. In wild-type mice, transgenic, cardiac-targeted, overexpression of corin enhanced cyclic guanosine monophosphate and blood pressure responses to pro-atrial natriuretic peptide, but did not affect heart size, contractility, body weights, survival, and blood pressure. In mice with dilated cardiomyopathy, corin overexpression significantly reduced the development of myocardial fibrosis (P<0.05). Corin overexpression also enhanced heart contractile function (fractional shortening and ejection fraction; P<0.01) and it significantly reduced heart failure as assessed by lung water (P<0.05) and alveolar congestion (P<0.001). Consistent with these observations, corin overexpression significantly prolonged life in mice with dilated cardiomyopathy (P<0.0001). These results provide the first experimental evidence that corin expression plays a role in cardiomyopathy by modulating myocardial fibrosis, cardiac function, heart failure, and survival.

AB - Heart failure, caused by dilated cardiomyopathy and other cardiac disorders such as hypertension, is a major public health problem with high morbidity and mortality. Corin, a cardiac enzyme that cleaves natriuretic peptides, is a promising biomarker of cardiomyopathy and heart failure, but its functional role in these processes is not understood. We evaluated the potential effects of corin in mice with a well-characterized model of dilated cardiomyopathy. Mice with dilated cardiomyopathy developed heart failure, reduced contractile function, cardiac fibrosis, and accelerated mortality in the setting of low corin expression. In wild-type mice, transgenic, cardiac-targeted, overexpression of corin enhanced cyclic guanosine monophosphate and blood pressure responses to pro-atrial natriuretic peptide, but did not affect heart size, contractility, body weights, survival, and blood pressure. In mice with dilated cardiomyopathy, corin overexpression significantly reduced the development of myocardial fibrosis (P<0.05). Corin overexpression also enhanced heart contractile function (fractional shortening and ejection fraction; P<0.01) and it significantly reduced heart failure as assessed by lung water (P<0.05) and alveolar congestion (P<0.001). Consistent with these observations, corin overexpression significantly prolonged life in mice with dilated cardiomyopathy (P<0.0001). These results provide the first experimental evidence that corin expression plays a role in cardiomyopathy by modulating myocardial fibrosis, cardiac function, heart failure, and survival.

UR - http://www.scopus.com/inward/record.url?scp=84873058628&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873058628&partnerID=8YFLogxK

U2 - 10.1161/HYPERTENSIONAHA.112.193631

DO - 10.1161/HYPERTENSIONAHA.112.193631

M3 - Article

VL - 61

SP - 327

EP - 332

JO - Hypertension

JF - Hypertension

SN - 0194-911X

IS - 2

ER -